Haemonetics' net profit under GAAP for 6 months of fiscal 2021 was $58.628 million, a 2-fold increase from $29.007 million in the previous year. Revenue decreased by 17.5% to $405.063 million against $491.017 million a year earlier.
Haemonetics' net profit under GAAP for 6 months of fiscal 2021 was $58.628 million, a 2-fold increase from $29.007 million in the previous year. Revenue decreased by 17.5% to $405.063 million against $491.017 million a year earlier. 
English (US) 